DiaMedica Therapeutics Announces 2024 Financial Results and Business Update
March 17, 2025 - 23:55
MINNEAPOLIS, March 17, 2025—DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for acute ischemic stroke and preeclampsia, has released its financial results for the year ending December 31, 2024. The company outlined its strategic initiatives and progress made over the past year, highlighting advancements in their clinical programs.
With a focus on addressing significant unmet medical needs, DiaMedica has made strides in its research efforts, particularly in the areas of acute ischemic stroke and preeclampsia. The company is committed to advancing its pipeline and believes that its innovative therapies have the potential to transform patient outcomes.
To further discuss these developments and the financial results, management will conduct a conference call on Tuesday, March 18, 2025, at 8:00 AM Eastern Time. This call will provide an opportunity for stakeholders to gain insights into the company’s future plans and ongoing projects.
MORE NEWS
June 3, 2025 - 00:08
Celebrating Achievement: Dayle Smith Honored with Distinguished Woman in Business Education AwardIn a significant recognition of her contributions to the field of business education, Dayle Smith has been awarded the Distinguished Woman in Business Education Award. This prestigious accolade...
June 2, 2025 - 02:15
Leadership Change at Twin Cities Habitat for HumanityTwin Cities Habitat for Humanity, a prominent advocate for affordable housing based in St. Paul, has announced the appointment of Catherine Penkert as its new chief of staff. Penkert brings a...
June 1, 2025 - 00:41
CEO of Atlanta Home Builder Faces Felony Charges Over Allegations of MisappropriationThe CEO of a prominent Atlanta-based home building company is back in court, facing serious felony charges stemming from alleged misconduct in business practices. Clients of the high-end builder...
May 31, 2025 - 09:09
Empowering Indigenous Businesses: The Impact of the Native American Collateral Support ProgramHELENA, MT – The Native American Collateral Support Program (NACS) is playing a crucial role in helping Indigenous-owned businesses in Montana by providing access to capital. This initiative aims...